{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:10:35Z","timestamp":1788441035936,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.pdpdt.2023.103804","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:19:31Z","timestamp":1694661571000},"page":"103804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of the effect of sodium-glucose cotransporter-2 inhibitor treatment on choroidal vascular parameters in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0791-3147","authenticated-orcid":false,"given":"Ruveyde","family":"Bolac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman","family":"BAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma Merve Arda","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevcan","family":"Balci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksan","family":"Alpogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pdpdt.2023.103804_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022188","article-title":"Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis","volume":"9","author":"Cheloni","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.pdpdt.2023.103804_bib0002","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12521","article-title":"Macro- and microvascular endothelial dysfunction in diabetes","volume":"9","author":"Shi","year":"2017","journal-title":"J. Diabetes"},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103804_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"4","key":"10.1016\/j.pdpdt.2023.103804_bib0004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.12696","article-title":"Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review","volume":"44","author":"Ting","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2023.103804_bib0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/dme.13564","article-title":"Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care","volume":"35","author":"Winocour","year":"2018","journal-title":"Diabet. Med."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.visres.2017.04.011","article-title":"Diabetic choroidopathy","volume":"139","author":"Lutty","year":"2017","journal-title":"Vision Res."},{"issue":"6","key":"10.1016\/j.pdpdt.2023.103804_bib0007","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3341\/kjo.2013.27.6.433","article-title":"Comparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography","volume":"27","author":"Lee","year":"2013","journal-title":"Korean J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pdpdt.2023.103804_bib0008","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/IAE.0b013e31825db73d","article-title":"Macular and peripapillary choroidal thickness in diabetic patients","volume":"32","author":"Vujosevic","year":"2012","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.pdpdt.2023.103804_bib0009","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1167\/iovs.12-11503","article-title":"Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients","volume":"54","author":"Kim","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100829","article-title":"Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index","volume":"77","author":"Agrawal","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"issue":"12","key":"10.1016\/j.pdpdt.2023.103804_bib0011","doi-asserted-by":"crossref","first-page":"e02074","DOI":"10.1371\/journal.pone.0207435","article-title":"Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-a novel OCT based imaging biomarker","volume":"13","author":"Gupta","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pdpdt.2023.103804_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8867875","article-title":"The role of SGLT2 inhibitor on the treatment of diabetic retinopathy","volume":"2020","author":"Sha","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"12","key":"10.1016\/j.pdpdt.2023.103804_bib0013","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","article-title":"Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes","volume":"54","author":"Rahmoune","year":"2005","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.pdpdt.2023.103804_bib0014","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/glycob\/cwx047","article-title":"Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy","volume":"27","author":"Wakisaka","year":"2017","journal-title":"Glycobiology."},{"issue":"5","key":"10.1016\/j.pdpdt.2023.103804_bib0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/dom.12064","article-title":"Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus","volume":"15","author":"Chen","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"10","key":"10.1016\/j.pdpdt.2023.103804_bib0016","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103804_bib0017","first-page":"17","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care."},{"issue":"2","key":"10.1016\/j.pdpdt.2023.103804_bib0018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","article-title":"A new predictive equation for resting energy expenditure in healthy individuals","volume":"51","author":"Mifflin","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.pdpdt.2023.103804_bib0019","first-page":"1","article-title":"A collection of Physical Activity Questionnaires for health-related research","volume":"29","author":"Pereira","year":"1997","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0020","doi-asserted-by":"crossref","first-page":"21090","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a populationbased study","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.pdpdt.2023.103804_bib0021","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/aos.13442","article-title":"Influence of scanning area on choroidal vascularity index measurement using optical coherence tomography","volume":"95","author":"Agrawal","year":"2017","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103804_bib0022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41598-017-18511-7","article-title":"Choroidal vascularity index in type-2 diabetes analyzed by swept-source optical coherence tomography","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.pdpdt.2023.103804_bib0023","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1167\/tvst.11.3.35","article-title":"Assessment of diabetic choroidopathy using ultra-widefield optical coherence tomography","volume":"11","author":"Nicolini","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103804_bib0024","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12886-019-1189-8","article-title":"Choroidal structural changes correlate with severity of diabetic retinopathy in diabetes mellitus","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819891886","article-title":"How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodology","volume":"10","author":"May","year":"2019","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.pdpdt.2023.103804_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112394","article-title":"The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity","volume":"9","author":"Oelze","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pdpdt.2023.103804_bib0027","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME Investigators, Empaglifozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.pdpdt.2023.103804_bib0028","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canaglifozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"DECLARE\u2013TIMI 58 Investigators, Dapaglifozin and car diovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.pdpdt.2023.103804_bib0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/dom.12261","article-title":"Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes","volume":"16","author":"Dziuba","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6807219","article-title":"Potent oral hypoglycemic agents for microvascular complication: sodium-glucose cotransporter 2 inhibitors for diabetic retinopathy","volume":"2018","author":"Cho","year":"2018","journal-title":"J. Diabetes Res."},{"issue":"8","key":"10.1016\/j.pdpdt.2023.103804_bib0032","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jfo.2021.01.005","article-title":"Do SGLT2 inhibitors prevent preclinical diabetic retinopathy? A prospective pilot optical coherence tomography angiography study","volume":"44","author":"Sabaner","year":"2021","journal-title":"J. Fr. Ophtalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103804_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12933-017-0510-1","article-title":"A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation","volume":"16","author":"Ott","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.pdpdt.2023.103804_bib0034","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212209","article-title":"Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy","volume":"42","author":"Matthews","year":"2022","journal-title":"Biosci Rep."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0035","article-title":"Sodium-glucose cotransporter 2 inhibitors improve chronic diabetic macular edema","volume":"2020","author":"Takatsuna","year":"2020","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"10.1016\/j.pdpdt.2023.103804_bib0036","doi-asserted-by":"crossref","first-page":"462","DOI":"10.12659\/AJCR.909708","article-title":"Recovery from diabetic macular edema in a diabetic patient after minimal dose of a sodium glucose co-transporter 2 inhibitor","volume":"19","author":"Yoshizumi","year":"2018","journal-title":"Am. J. Case Rep."},{"issue":"6","key":"10.1016\/j.pdpdt.2023.103804_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101280","article-title":"ADDENDA-BHS2 trial investigators, Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: a randomized controlled trial","volume":"47","author":"Fernandes","year":"2021","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.pdpdt.2023.103804_bib0038","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12886-016-0227-z","article-title":"Choroidal thickness in obese women","volume":"16","author":"Yumusak","year":"2016","journal-title":"BMC Ophthalmol."},{"issue":"7","key":"10.1016\/j.pdpdt.2023.103804_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235926","article-title":"Effect of weight loss on the retinochoroidal structural alterations among patients with exogenous obesity","volume":"15","author":"Agarwal","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pdpdt.2023.103804_bib0040","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1177\/11206721211043751","article-title":"Association of choroidal structure and body mass index in an adult population","volume":"32","author":"Temel","year":"2022","journal-title":"Eur. J. Ophthalmol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100023005318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100023005318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T19:30:04Z","timestamp":1733254204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100023005318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"alternative-id":["S1572100023005318"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103804","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the effect of sodium-glucose cotransporter-2 inhibitor treatment on choroidal vascular parameters in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103804"}}